FOXO3a in cancer drug resistance
Y Liu, Y Wang, X Li, Y Jia, J Wang, X Ao - Cancer Letters, 2022 - Elsevier
Cancer is one of the major causes of death and a significant obstacle to increasing life
expectancy worldwide. Chemotherapy remains the first-line adjuvant therapeutic option for …
expectancy worldwide. Chemotherapy remains the first-line adjuvant therapeutic option for …
FOXO3a in cancer drug resistance.
Y Liu, Y Wang, X Li, Y Jia, J Wang, X Ao - Cancer Letters, 2022 - europepmc.org
Cancer is one of the major causes of death and a significant obstacle to increasing life
expectancy worldwide. Chemotherapy remains the first-line adjuvant therapeutic option for …
expectancy worldwide. Chemotherapy remains the first-line adjuvant therapeutic option for …
FOXO3a in cancer drug resistance
Y Liu, Y Wang, X Li, Y Jia, J Wang, X Ao - Cancer letters, 2022 - pubmed.ncbi.nlm.nih.gov
Cancer is one of the major causes of death and a significant obstacle to increasing life
expectancy worldwide. Chemotherapy remains the first-line adjuvant therapeutic option for …
expectancy worldwide. Chemotherapy remains the first-line adjuvant therapeutic option for …